Intercom was founded in 2011 by Eoghan McCabe, Des Traynor, Ciaran Lee, and David Barrett. Intercom has not officially endorsed a plan to participate in an IPO.
Intercom is a Conversational Relationship platform that helps businesses build better customer relationships through personalized, messenger-based experiences. Per Forge data, Intercom raised $240.8 million in funding over 8 rounds. Their latest funding was raised on Dec 1, 2020. Key investors include Social Capital, Kleiner Perkins, Bessemer Ventures, and Index Ventures.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/17/2018 | Series D | $125MM | $xx.xx | $127.5B | Bessemer Venture Partners, Founders Circle Capital, Gv, Index Ventures, Jack Dorsey, Kleiner Perkins, Mark Zuckerberg | |
Price per Share
$xx.xx
Shares Outstanding
2,692,058
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Founders Circle Capital, Gv, Index Ventures, Jack Dorsey, Kleiner Perkins, Mark Zuckerberg
|
||||||
04/07/2016 | Series C-1 | $50.1MM | $xx.xx | $51.03B | Bessemer Venture Partners, Iconiq Capital, Index Ventures (Uk), Jason Fried, Social Capital, Stewart Butterfield | |
Price per Share
$xx.xx
Shares Outstanding
2,293,050
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Iconiq Capital, Index Ventures (Uk), Jason Fried, Social Capital, Stewart Butterfield
|
||||||
08/26/2015 | Series C | $35MM | $xx.xx | $29.07B | Bessemer Venture Partners, Iconiq Capital, Social+Capital Partnership | |
Price per Share
$xx.xx
Shares Outstanding
2,565,644
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bessemer Venture Partners, Iconiq Capital, Social+Capital Partnership
|
||||||
01/22/2014 | Series B | $22.75MM | $xx.xx | $8.14B | Ashhill Pharma, Bessemer Venture Partners, Brandon Capital, Kernel, Venbio | |
Price per Share
$xx.xx
Shares Outstanding
4,652,066
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ashhill Pharma, Bessemer Venture Partners, Brandon Capital, Kernel, Venbio
|
||||||
06/19/2013 | Series A | $8.52MM | $xx.xx | $2.84B | Conor Stanley, David Sacks, Freestyle Capital, Social+Capital Partnership | |
Price per Share
$xx.xx
Shares Outstanding
4,503,050
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Conor Stanley, David Sacks, Freestyle Capital, Social+Capital Partnership
|